Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent progress in understanding apolipoprotein B.

S G Young1

  • 1Department of Medicine, University of California, San Francisco 94140-0608.

Circulation
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heterogeneity in the properties of mutant secreted lymphocyte antigen 6/urokinase receptor-related protein 1 (SLURP1) in Mal de Meleda.

The British journal of dermatology·2015
Same author

Stable isotope imaging of biological samples with high resolution secondary ion mass spectrometry and complementary techniques.

Methods (San Diego, Calif.)·2014
Same author

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins.

Journal of internal medicine·2012
Same author

Genetic abnormalities in apolipoprotein B.

Trends in cardiovascular medicine·2011
Same author

Generation of transgenic mice from yeast artificial chromosome DNA that has been modified by gene targeting.

Trends in cardiovascular medicine·2011
Same author

Farnesylation of Pex19p is not essential for peroxisome biogenesis in yeast and mammalian cells.

Cellular and molecular life sciences : CMLS·2006
Same journal

Eugene Braunwald, MD, 1929-2026.

Circulation·2026
Same journal

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Circulation·2026
Same journal

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Circulation·2026
Same journal

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Circulation·2026
Same journal

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same journal

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026
See all related articles

Apolipoprotein B-100 (apo B-100) and apo B-48 are key proteins in lipid transport and metabolism. Mutations in the apo B-100 gene can lead to hypercholesterolemia and increase the risk of atherosclerotic disease.

Area of Science:

  • Biochemistry
  • Genetics
  • Cardiovascular Science

Background:

  • Apolipoprotein B (apo B) encompasses two major plasma proteins: apo B-100 and apo B-48.
  • Apo B-100, synthesized in the liver, is essential for VLDL and LDL assembly and receptor-mediated uptake.
  • Apo B-48, produced in the intestine, is critical for dietary fat absorption via chylomicron formation.

Purpose of the Study:

  • To elucidate the structure-function relationships of apo B-100 and apo B-48.
  • To understand the genetic basis and clinical implications of apo B gene mutations.
  • To investigate the role of apo B in lipid metabolism and atherosclerotic disease.

Main Methods:

  • Characterization of apo B protein structure and function.
  • Genetic analysis of the apo B gene and its mutations.

Related Experiment Videos

  • Plasma lipid and lipoprotein profiling in relation to apo B levels and mutations.

    • Main Results:

    • Apo B-100's LDL receptor-binding region is in its carboxyterminal portion, while lipid-binding regions are dispersed.
    • Apo B-48 is a truncated form of apo B-100, resulting from mRNA editing.
    • Elevated apo B-100 is a risk factor for premature atherosclerotic disease.
    • A specific apo B-100 mutation (at amino acid 3,500) causes familial defective apo B-100, leading to hypercholesterolemia and increased cardiovascular risk.

    Conclusions:

    • Apo B-100 and apo B-48 play distinct yet crucial roles in lipoprotein metabolism.
    • Genetic variations in the apo B gene significantly impact plasma lipid levels and cardiovascular health.
    • Familial defective apo B-100 is a genetic cause of hypercholesterolemia and premature atherosclerosis.